Literature DB >> 18226835

Synthesis and in vitro antitumoral activity of novel O,O'-di-2-alkyl-(S,S)-ethylenediamine-N,N'-di-2-propanoate ligands and corresponding platinum(II/IV) complexes.

Bojana B Krajcinović1, Goran N Kaluderović, Dirk Steinborn, Harry Schmidt, Christoph Wagner, Zeljko Zizak, Zorica D Juranić, Srećko R Trifunović, Tibor J Sabo.   

Abstract

Syntheses of two novel ligand precursors O,O'-diisopropyl- (1a) and O,O'-diisobutyl-(S,S)-ethylenediamine-N,N'-di-2-propanoate dihydrochloride monohydrate (1b) and the corresponding dichloroplatinum(II) (2a and 2b) and tetrachloroplatinum(IV) complexes (3a and 3b) are described here. The substances were characterized by IR, (1)H and (13)C spectroscopy and elemental analysis. Crystal structures were determined for 1a and the corresponding platinum(IV) complex, 3a. In vitro antiproliferative activity was determined against tumor cell lines: human adenocarcinoma HeLa, human myelogenous leukemia K562, human malignant melanoma Fem-x, rested and stimulated normal immunocompetent cells (human peripheral blood mononuclear PBMC cells) using KBR test (Kenacid Blue Dye binding test). The IC(50)(microM) values for the most active compound 3a were: 30.48+/-2.54; 12.26+/-2.60; 13.68+/-3.22; 80.18+/-24.07 and 71.30+/-21.70, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18226835     DOI: 10.1016/j.jinorgbio.2007.12.009

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  3 in total

1.  Oxidative Reactivity and Cytotoxic Properties of a Platinum(II) Complex Prepared by Outer-Sphere Amide Bond Coupling.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Polyhedron       Date:  2013-07-13       Impact factor: 3.052

2.  N,N'-Bis[2-(methoxycarbonyl)ethyl]ethane-1,2-diammonium dichloride.

Authors:  Goran N Kaluderović; Anchan Paethanom; Christoph Wagner; Tibor J Sabo; Harry Schmidt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-06-07

3.  In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent.

Authors:  Ulrike Olszewski; Florian Ach; Ernst Ulsperger; Gerhard Baumgartner; Robert Zeillinger; Patrick Bednarski; Gerhard Hamilton
Journal:  Met Based Drugs       Date:  2009-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.